| Product NDC: | 0065-0627 |
| Proprietary Name: | Vexol |
| Non Proprietary Name: | rimexolone |
| Active Ingredient(s): | 10 mg/mL & nbsp; rimexolone |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0065-0627 |
| Labeler Name: | Alcon Laboratories, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020474 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19950915 |
| Package NDC: | 0065-0627-03 |
| Package Description: | 10 mL in 1 BOTTLE, PLASTIC (0065-0627-03) |
| NDC Code | 0065-0627-03 |
| Proprietary Name | Vexol |
| Package Description | 10 mL in 1 BOTTLE, PLASTIC (0065-0627-03) |
| Product NDC | 0065-0627 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rimexolone |
| Dosage Form Name | SUSPENSION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19950915 |
| Marketing Category Name | NDA |
| Labeler Name | Alcon Laboratories, Inc |
| Substance Name | RIMEXOLONE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |